| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.009 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.009 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.13 | 0.01 |